Journal article
Do p38 mitogen-activated protein kinase inhibitors have a future for the treatment of cardiovascular disease?
AR Kompa
Journal of Thoracic Disease | PIONEER BIOSCIENCE PUBL CO | Published : 2016
Abstract
Acute coronary syndrome (ACS) is associated with a significant risk of cardiovascular death, and recurrent ischemic events including myocardial infarction (MI). Therapeutic interventions for the management of ACS utilize a thrombolytic approach, although this is associated with an increased risk of bleeding.
Grants
Awarded by National Health and Medical Research Council of Australia
Funding Acknowledgements
Funding: Grant Support from the National Health and Medical Research Council of Australia (Program Grant 1092642).